Discover how urinary microRNA biomarkers can non-invasively identify aggressive bladder cancer subtypes. Read more on this ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...

(Nanowerk Spotlight) Cancer treatments have traditionally involved a difficult balance between effectiveness and side effects. For skin cancers, this challenge is particularly pronounced. Researchers ...

Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease. Current diagnostic methods, such as prostate-specific antigen (PSA) testing and ...

Small RNA was isolated from circulating tumor exosomes using mirVana isolation kit (Ambion, Austin, TX), and this low-molecular-weight RNA–enriched fraction was used for miRNA profiling as defined by ...

PROSTOX predicts late genitourinary toxicity, yielding area under the curve of 0.76. (HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is ...

De-escalation of axillary surgery in breast cancer patients with 1-2 positive sentinel nodes after neoadjuvant systemic therapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

MicroRNAs, whose discovery was recognized with the 2025 Nobel Prize in Physiology or Medicine, are central regulators of gene ...

This study validated PROSTOX as predicting radiotherapy-induced genitourinary toxicity, which can be differentiated into acute and chronic with mirSNP-based signatures, in patients with prostate ...